Integrated therapeutic plasma exchange and traditional Chinese medicine treatment in a patient with severe COVID-19: A case report.

Chia-Wei Lin, Wei-Chen Hsu, Chien-Lu Lu, Su-Hsing Cheng, Cheng-Pin Chen, Yu-Chang Hou
Author Information
  1. Chia-Wei Lin: Department of Chinese Medicine, Taoyuan General Hospital, Taoyuan City 330, Taiwan, China.
  2. Wei-Chen Hsu: Department of Chinese Medicine, Taoyuan General Hospital, Taoyuan City 330, Taiwan, China.
  3. Chien-Lu Lu: Department of Nephrology, Taoyuan General Hospital, Taoyuan City 330, Taiwan, China.
  4. Su-Hsing Cheng: Department of Infectious Disease, Taoyuan General Hospital, Taoyuan City 330, Taiwan, China; School of Public Health, Taipei Medical University, Taipei City 110, Taiwan, China.
  5. Cheng-Pin Chen: Department of Infectious Disease, Taoyuan General Hospital, Taoyuan City 330, Taiwan, China. Electronic address: jangbin@gmail.com.
  6. Yu-Chang Hou: Department of Chinese Medicine, Taoyuan General Hospital, Taoyuan City 330, Taiwan, China; Department of Bioscience Technology, Chung Yuan Christian University, Taoyuan City 320, Taiwan, China; School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung City 404, Taiwan, China; School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan City 333, Taiwan, China. Electronic address: houyc0115@gmail.com.

Abstract

This report presents the case of a 59-year-old man with severe COVID-19 that gradually progressed to cytokine release syndrome and then acute respiratory distress syndrome; he was successfully treated via integration of therapeutic plasma exchange and traditional Chinese medicine. The patient initially presented with a sore throat, severe muscle aches, productive cough and fever. On the worsening of symptoms, remdesivir was administered. However, as the symptoms continued to worsen and a cytokine release syndrome was suspected, oxygen was provided through a high-flow nasal cannula (50 L/min) and therapeutic plasma exchange was performed to prevent worsening of the acute respiratory distress syndrome. On the same day, a course of traditional Chinese medicine was introduced in consultation with the infectious house staff. The patient's symptoms gradually improved; the levels of C-reactive protein and D-dimers reduced, and the patient was weaned to a simple oxygen mask and eventually to room air. This is the first reported case of the integration of these treatments. Together, they prevented the patient from requiring intubation, played a role in cytokine management, and also improved the clinical symptoms, including productive purulent sputum, cough, frequent stool passage and intermittent fever, with no adverse effects. As a result, the patient was discharged within two weeks of the integration of these treatments. Therefore, the integration of therapeutic plasma exchange and traditional Chinese medicine is an effective therapy for patients with severe COVID-19.

Keywords

References

  1. J Evid Based Med. 2021 Dec;14(4):313-332 [PMID: 34632732]
  2. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2018 Jan 8;34(1):57-60 [PMID: 29926660]
  3. Front Public Health. 2021 Jul 09;9:687283 [PMID: 34307281]
  4. Chin J Integr Med. 2021 May;27(5):375-378 [PMID: 33528745]
  5. Am J Chin Med. 2017;45(2):225-238 [PMID: 28231744]
  6. Science. 2020 May 1;368(6490):473-474 [PMID: 32303591]
  7. Crit Care. 2018 Oct 30;22(1):285 [PMID: 30373638]
  8. Phytomedicine. 2021 May;85:153242 [PMID: 33867046]
  9. Int J Mol Sci. 2019 Apr 03;20(7): [PMID: 30987173]
  10. Evid Based Complement Alternat Med. 2009 Mar;6(1):57-63 [PMID: 18955220]
  11. Biomed Pharmacother. 2021 Jan;133:111037 [PMID: 33249281]
  12. BMC Complement Altern Med. 2018 Nov 29;18(1):313 [PMID: 30497462]
  13. Vox Sang. 2021 Aug;116(7):798-807 [PMID: 33730761]
  14. Med Acupunct. 2021 Feb 1;33(1):92-102 [PMID: 33613817]
  15. Ann Allergy Asthma Immunol. 2014 May;112(5):465-70 [PMID: 24656660]
  16. Chin J Integr Med. 2020 Sep;26(9):648-655 [PMID: 32676976]
  17. Am J Transl Res. 2016 Mar 15;8(3):1609-14 [PMID: 27186286]
  18. Complement Ther Med. 2020 Aug;52:102473 [PMID: 32951723]
  19. Zhongguo Zhong Yao Za Zhi. 2010 Apr;35(8):1068-72 [PMID: 20617696]
  20. Front Med. 2020 Dec;14(6):752-759 [PMID: 32926320]
  21. BMC Complement Altern Med. 2016 Nov 10;16(1):456 [PMID: 27832784]
  22. Fundam Clin Pharmacol. 2014 Jun;28(3):268-76 [PMID: 23413967]
  23. PLoS One. 2021 Jan 7;16(1):e0244853 [PMID: 33411791]
  24. Pharmacol Res. 2021 Dec;174:105955 [PMID: 34715330]
  25. J Tradit Chin Med. 2016 Jun;36(3):369-76 [PMID: 27468553]
  26. Phytomedicine. 2014 Mar 15;21(4):529-33 [PMID: 24290472]
  27. J Ethnopharmacol. 2018 Jun 28;220:265-282 [PMID: 29628291]
  28. Int J Antimicrob Agents. 2021 May;57(5):106334 [PMID: 33838224]
  29. Crit Care. 2020 Aug 8;24(1):492 [PMID: 32771054]
  30. Front Pharmacol. 2020 Nov 26;11:581691 [PMID: 33324213]

MeSH Term

Male
Humans
Middle Aged
COVID-19
Cytokine Release Syndrome
Plasma Exchange
Medicine, Chinese Traditional
Cough
Respiratory Distress Syndrome
Oxygen

Chemicals

Oxygen

Word Cloud

Created with Highcharts 10.0.0plasmaexchangeChinesemedicinepatientseveresyndromeintegrationtherapeutictraditionalsymptomscaseCOVID-19cytokinereportgraduallyreleaseacuterespiratorydistressproductivecoughfeverworseningoxygenimprovedtreatmentspresents59-year-oldmanprogressedsuccessfullytreatedviainitiallypresentedsorethroatmuscleachesremdesiviradministeredHowevercontinuedworsensuspectedprovidedhigh-flownasalcannula50 L/minperformedpreventdaycourseintroducedconsultationinfectioushousestaffpatient'slevelsC-reactiveproteinD-dimersreducedweanedsimplemaskeventuallyroomairfirstreportedTogetherpreventedrequiringintubationplayedrolemanagementalsoclinicalincludingpurulentsputumfrequentstoolpassageintermittentadverseeffectsresultdischargedwithintwoweeksThereforeeffectivetherapypatientsIntegratedtreatmentCOVID-19:TherapeuticTraditional

Similar Articles

Cited By